Essential updates 2021/2022: Perioperative and surgical treatments for gastric and esophagogastric j...
Essential updates 2021/2022: Perioperative and surgical treatments for gastric and esophagogastric junction cancer
About this item
Full title
Author / Creator
Publisher
Japan: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Japan: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
In recent years, important clinical trials for gastric cancer (GC) and esophagogastric junction cancer (EGJC) have been reported, changing the strategies of surgical and perioperative treatment. Although laparoscopic gastrectomy has already been shown to be effective for early‐stage cancer, recent evidence from both Asia (JLSSG0901, CLASS‐01 and KL...
Alternative Titles
Full title
Essential updates 2021/2022: Perioperative and surgical treatments for gastric and esophagogastric junction cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_570bc36989f34f71875e7bbeb3811196
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_570bc36989f34f71875e7bbeb3811196
Other Identifiers
ISSN
2475-0328
E-ISSN
2475-0328
DOI
10.1002/ags3.12711
